Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.

Expert review of anticancer therapy - 1 Dec 2016

Weinberger Vit, Bednarikova Marketa, Cibula David, Zikan Michal

Abstract excerpt

INTRODUCTION: Serous tubal intraepithelial carcinoma (STIC) is most likely precursor lesion of the most part of high-grade serous pelvis carcinomas, carcinosarcoma and undifferentiated carcinoma with incidence of 0.6% to 7% in BRCA carriers or women with strong family history of breast or ovarian carcinoma. STIC is a pathomorphologically and immunohistochemically detectable lesion which biological significance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Carcinoma in Situ

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Fallopian Tube Neoplasms

Share to Immunohistochemistry

Share to Incidence

Share to Neoplasms, Cystic, Mucinous, and Serous

Source

Identifiers

PMID: 27732120
DOI: 10.1080/14737140.2016.1247699

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.PMID 27732120Read ↗

Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.Semantic proximity Read ↗

Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland.Semantic proximity Read ↗

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).Semantic proximity Read ↗

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.Semantic proximity Read ↗

Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).Semantic proximity Read ↗

High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening FugitiveSemantic proximity Read ↗

Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.Semantic proximity Read ↗

Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.Semantic proximity Read ↗

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.Semantic proximity Read ↗

Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer.Semantic proximity Read ↗

Next-Generation Sequencing of Tubal Intraepithelial Carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.